Inventor · disambiguated record
Yanran Ai
Also filed as: AI YANRAN
8 granted patents·13 pending applications·14 citations·filing 2019–2025
80Inventor score
Files withINCYTE CORP21
Top patents by PatentIndex Score
21 records- 0195US11780840B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Oct 10, 2023·4 cites·12 claims
- 0290US11046658B2Aminopyrazine derivatives as PI3K-γ inhibitorsINCYTE CORP·Filed 2019·Granted Jun 29, 2021·4 cites·23 claims
- 0387US11161838B2Heterocyclic derivatives as PI3K inhibitorsINCYTE CORP·Filed 2019·Granted Nov 2, 2021·4 cites·39 claims
- 0483US12187725B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2023·Granted Jan 7, 2025·0 cites·42 claims
- 0583US11078204B2Heterocyclic derivatives as PI3K inhibitorsINCYTE CORP·Filed 2019·Granted Aug 3, 2021·2 cites·46 claims
- 0682US2025388553A1AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORSINCYTE CORP·Filed 2025·Application pending·0 cites
- 0781US2025320212A1Tricyclic urea compounds as jak2 v617f inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0873US12084430B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2023·Granted Sep 10, 2024·0 cites·12 claims
- 0970US12421197B2Aminopyrazine derivatives as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Sep 23, 2025·0 cites·28 claims
- 1069US2025122170A1Tricyclic urea compounds as jak2 v617f inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1168US2025333420A1Fused bicyclic pyrimidones as wrn inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1267US2025236622A1Bicyclic compounds as inhibitors of wrnINCYTE CORP·Filed 2024·Application pending·0 cites
- 1367US2025333419A1Bicyclic compounds as inhibitors of wrnINCYTE CORP·Filed 2024·Application pending·0 cites
- 1467US2025270218A1Imidaz0[1,2-a]pyrimidine-5(1 h)-ones as wrn inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1566US2024317744A1Bicyclic Ureas As Kinase InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1666US2025215006A1Tricyclic compounds as inhibitors of wrnINCYTE CORP·Filed 2024·Application pending·0 cites
- 1764US12006320B2Heterocyclic derivatives as PI3K inhibitorsINCYTE CORP·Filed 2021·Granted Jun 11, 2024·0 cites·33 claims
- 1864US2025092044A1Kinase InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1964US2025270217A1Imidaz0[1,2-a]pyrimidine-5(1 h)-ones having a covalent warhead at the 3-position as wrn inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2064US2024300948A1Heterocyclic Compounds As Kinase InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2164US2025092043A1Kinase Inhibitors and DegradersINCYTE CORP·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yanran Ai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →